COVID‐19 Vaccine‐Induced Severe Pneumonitis
Open Access
- 21 August 2025
- journal article
- Published by Wiley in Respirology Case Reports
- Vol. 13 (8)
Abstract
Coronavirus disease 2019 (COVID‐19) has resulted in global morbidity, mortality, and societal disruption. COVID‐19 mRNA vaccination was mandatory in many countries for a period; however, severe adverse events have been observed in some individuals who received the vaccine. We report a case of COVID‐19 mRNA vaccine‐induced pneumonitis in a male patient whose cytokine levels were analysed prior to admission. His serum IgE level was high (347 U/mL), and several cytokines were elevated: TNFα was 1.2 pg/mL, IL‐6 was 156 pg/mL, and IL‐8 was 75.0 pg/mL. The patient developed severe respiratory failure requiring ventilatory support but recovered after steroid pulse therapy.Keywords
This publication has 5 references indexed in Scilit:
- COVID-19 vaccines adverse events: potential molecular mechanismsImmunologic Research, 2023
- The WHO estimates of excess mortality associated with the COVID-19 pandemicNature, 2022
- The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus ApproachThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Interleukin-8 plays a significant role in IgE-mediated lung inflammationEuropean Respiratory Journal, 1998